Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. AdvaMed confirms ex-BIO COO Whitaker is new CEO
AdvaMed, the national lobby for the medical device industry, confirmed that it tapped the chief operating officer at BIO, Scott Whitaker, to be its new CEO.
Whitaker is due to replace Steve Ubl, who left last year to take the reins at PhRMA, effective April 4. Read more
2. FDA panel recommends deep, long-term monitoring for leadless pacemakers
An FDA advisory panel recommended deep, long-term surveillance of the leadless pacemakers being developed by the 4 leading companies in the cardiac rhythm management space.
Medtronic, St. Jude Medical, Boston Scientific and Biotronik are all developing versions of a leadless pacemaker designed to be implanted directly into the heart’s right ventricle, eschewing the need for the leads used in conventional pacers. Read more
1. Johnson & Johnson loses another pelvic mesh suit
A federal jury in Georgia deliberated for 3 hours before delivering a another loss to Johnson & Johnson in a product liability lawsuit brought over pelvic mesh products.
The jury in the U.S. District Court for Middle Georgia awarded plaintiff Teresa Taylor $400,000 in compensatory damages and $4 million in punitive damages after finding that the Mentor ObTape transobdturator vaginal sling she had implanted in March 2014 caused her injuries. Read more
The post MassDevice.com +3 | The top 3 medtech stories for February 19, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1oykXmB
Cap comentari:
Publica un comentari a l'entrada